Sipcam to evaluate Eden Research's two new products

Date:05-21-2015

Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, recently announced that it has signed a new Evaluation Agreement  with Sipcam Italia Spa and Sipcam Iberia to evaluate two new products targeting additional important crop diseases. In November 2014, Sipcam took an exclusive licence to Eden's first product, 3AEY, for the treatment of botrytis. This product will be launched following the completion of the EU product registration allowing the sale and use of 3AEY on grapes, initially, across the Southern EU zone.

Following the successful work with 3AEY, Sipcam is expanding its evaluations of Eden's technologies by conducting field trials on two new Eden products for the treatment of powdery mildew, which affects flowers and fruit, and apple scab during the course of 2015. These products are also based upon combinations of Eden's EU approved terpenes and its patented micro-encapsulation technology, GO-E™. It is anticipated that Sipcam will expand its evaluations in 2016 and potentially begin the product registration process under a new licence from Eden should the trials prove to be conclusive during the course of 2015.

Financial terms of the Agreement are subject to confidentiality and have not been disclosed.